<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04898088</url>
  </required_header>
  <id_info>
    <org_study_id>8860/9193</org_study_id>
    <nct_id>NCT04898088</nct_id>
  </id_info>
  <brief_title>A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients</brief_title>
  <acronym>REPAIR</acronym>
  <official_title>A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Istinye University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Liv Hospital (Ulus)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our aim in this study is to determine the positive effect of stem cell therapy applied on&#xD;
      critically ill patients with coronavirus infection on DNA repair genes.&#xD;
&#xD;
      Patients diagnosed with COVID-19 infection are divided into two equal (n:30) groups.&#xD;
      Group-1(n/15): Patients in critically ill condition receiving conventional therapy, Group-2&#xD;
      (n/15): Patients in critically ill condition receiving conventional therapy and systemically&#xD;
      transplanted MSCs. The DNA repair pathway will be examined as 11 genes in 5 different parts.&#xD;
      Investigated parameters:&#xD;
&#xD;
        1. Base excision repair&#xD;
&#xD;
        2. Nucleotide excision repair&#xD;
&#xD;
        3. Recombinational repair&#xD;
&#xD;
        4. Mismatch repair&#xD;
&#xD;
        5. Direct reversal Investigated parameters: broad biochemical analysis, apoptosis, clinical&#xD;
           outcome, and mortality rates.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our aim in this study is to determine the positive effect of stem cell therapy applied on&#xD;
      critically ill patients with coronavirus infection on DNA repair genes.&#xD;
&#xD;
      Patients diagnosed with COVID-19 infection are divided into two equal (n:30) groups.&#xD;
      Group-1(n/15): Patients in critically ill condition receiving conventional therapy, Group-2&#xD;
      (n/15): Patients in critically ill condition receiving conventional therapy and systemically&#xD;
      transplanted MSCs. The DNA repair pathway will be examined as 11 genes in 5 different parts.&#xD;
      Investigated parameters:&#xD;
&#xD;
        1. Base excision repair&#xD;
&#xD;
        2. Nucleotide excision repair&#xD;
&#xD;
        3. Recombinational repair&#xD;
&#xD;
        4. Mismatch repair&#xD;
&#xD;
        5. Direct reversal Investigated parameters: broad biochemical analysis, apoptosis, clinical&#xD;
           outcome, and mortality rates.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Actual">September 30, 2020</completion_date>
  <primary_completion_date type="Actual">August 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Expression of PARP1 gene as indicator of base excision repair</measure>
    <time_frame>6 months</time_frame>
    <description>Expression of PARP1 gene as indicator of base excision repair</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expression of genes ATM, RAD51, RAD52 and WRN as indicator of Recombinational repair</measure>
    <time_frame>6 months</time_frame>
    <description>Expression of genes ATM, RAD51, RAD52 and WRN as indicator of Recombinational repair</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expression of genes RAD23B and ERCC1 as indicator of Nucleotide excision repair</measure>
    <time_frame>6 months</time_frame>
    <description>Expression of genes RAD23B and ERCC1as indicator of Nucleotide excision repair</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expression of genes MLH1, MSH2 and MSH6as indicator of Mismatch repair</measure>
    <time_frame>6 months</time_frame>
    <description>Expression of genes MLH1, MSH2 and MSH6 as indicator of Mismatch repair</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>COVID-19 Pneumonia</condition>
  <arm_group>
    <arm_group_label>Conventional Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Therapy with Add-On MSC therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Mesenchymal Stem Cells Transplantation</intervention_name>
    <description>Mesenchymal Stem Cells Transplantation applied as three intravenous infusions with 30 days intervals</description>
    <arm_group_label>Conventional Therapy</arm_group_label>
    <arm_group_label>Conventional Therapy with Add-On MSC therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 40-65 years old male/female.&#xD;
&#xD;
          2. Obtaining informed consent from him or his legal relative.&#xD;
&#xD;
          3. Confirmed COVID-19 related severe ARDS cases.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        pregnant, malignant tumours, the ones who has confirmed co-infection; history of using&#xD;
        long-term immunosuppressive agents&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Istinye University</name>
      <address>
        <city>Istanbul</city>
        <zip>34010</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi</name>
      <address>
        <city>Istanbul</city>
        <zip>34147</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 21, 2021</study_first_submitted>
  <study_first_submitted_qc>May 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2021</study_first_posted>
  <last_update_submitted>May 21, 2021</last_update_submitted>
  <last_update_submitted_qc>May 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>Critical Case</keyword>
  <keyword>DNA Repair</keyword>
  <keyword>DAN damage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

